January 12-15, 2026 | San Francisco Marriott Marquis, CA
WE ARE NOT ACCEPTING MEETINGS WITH CROs and CMOs, THANKS.
A new pharmaceutical company specialized in the development and commercialization of orphan drugs, excluding those for cancer and infectious diseases, in Japan under DyDo Group Holdings Inc.